Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acetaminophen + naproxen sodium is a combination of two analgesic drugs used to relieve mild to moderate pain and reduce fever. Acetaminophen acts primarily as an analgesic and antipyretic by inhibiting the release of substances in the brain that cause pain sensation, though its precise mechanism is not fully understood. Naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) that works by blocking the formation of prostaglandins, substances responsible for inflammation and pain. This combination provides both anti-inflammatory effects (from naproxen) and central pain relief (from acetaminophen), making it useful for conditions such as headaches, muscle aches, menstrual cramps, arthritis, toothaches, sore throats, and other sources of mild to moderate pain[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + naproxen sodium.